SNAP25 and pancreatic insulinoma: It has been reported that insulinoma cells are refractory to BoNT/A binding (Boyd et al. 1995); however, our highly sensitive cleaved-SNAP25 immunoassay does reveal some efficacy of botulinum-based targeting (Bitox) (Fig. 2b).